AVAH Stock Analysis: Buy, Sell, or Hold?
AVAH - Aveanna Healthcare Holdings Inc. Common Stock
$13.70
0.54 (4.07%)
▲
5d:
+7.92%
30d:
+44.92%
90d:
+86.83%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When AVAH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: AVAH is 14.6% above its trading range ($11.95). Market expects 8.8% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: AVAH is 14.6% above its trading range ($11.95). Market expects 8.8% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$12.81
Based on 4.7% avg growth
INTRINSIC VALUE TODAY
$7.96
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AVAH is currently trading at $13.70, which is considered extended relative to its 30-day fair value range of $8.90 to $11.95. From a valuation perspective, the stock is trading at a premium (Forward PE: 15.2) compared to its historical average (11.8). At these levels, the market is pricing in 8.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, AVAH is in a strong uptrend. The price is approaching resistance at $13.98. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.1% recently.
Market Sentiment: AVAH scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AVAH is in a strong uptrend. The price is approaching resistance at $13.98. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.1% recently.
Market Sentiment: AVAH scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$8.90 -
$11.95
Company Quality Score
33/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
15.7%
Protect Your Profits
AVAH is technically overbought (RSI 81). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+14.6% above its trading range)
- BEARISH: Weak technical setup (5/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.1%)
- BEARISH: Trading above Wall St target ($12.35)
- NEUTRAL: Trading at premium valuation - market expects 8.8% growth which is achievable
- WARNING: Composite score 33/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$8.90 -
$11.95
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$8.76
Resistance Level
$13.98
Current Trend
Strong Uptrend
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.21
Wall Street Target
$12.35
(-6.2%)
Revenue Growth (YoY)
13.7%
Earnings Growth (YoY)
38.5%
Profit Margin
10.6%
Valuation Premium vs History
+8.8% premium
PE vs Historical
15.2 vs 11.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+8.8%
(market-implied from PE analysis)
1-Year Target
$14.32
(+9%)
2-Year Target
$15.58
(+18%)
3-Year Target
$16.95
(+29%)
3-Yr Target (if PE normalizes)
(PE: 15→12)
PE COMPRESSION
$13.15
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 5.3%)
$20.29
(+54%)
Base:
(SPY PE: 15.2, Growth: 5.3%)
$15.38
(+17%)
Bear:
(PE: 11.8, Growth: 5.3%)
$11.93
(-9%)
📈
Valuation based on Current Earnings
Trailing PE: 10.05 | Current EPS (TTM): $1.31
Bull Case
$9.56
(-27%)
Analyst growth -34.0%, PE expands to 11.1
Base Case
$8.69
(-34%)
Market implied -34.0%, PE stable at 10.1
Bear Case
$8.95
(-32%)
Severe decline -20.0%, PE contracts to 8.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 24, 2026 2:08 PM ET
Data refreshes hourly during market hours. Next update: 3:08 PM
Data refreshes hourly during market hours. Next update: 3:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AVAH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$282 | 34 SELL |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$451 | 43 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 41 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 40 SELL |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$135 | 48 HOLD |
Advanced AVAH Option Strategies
Professional options setups generated by AI based on today's AVAH price and gamma walls.
